Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank I Scott

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Digestive Diseases and Sciences|April 28, 2020
Infliximab Versus Biosimilars for IBD: Is It Better to Fight Than Switch?Frank I Scott
Crohn'S & Colitis 360|May 5, 2020
Marijuana Use in Inflammatory Bowel Disease: Understanding the Prevalence and the Potential PitfallsFrank I Scott
Current Opinion in Gastroenterology|May 27, 2020
The treatment approach to inflammatory bowel disease in 2020Ashley Vachon, Frank I Scott
Gastroenterology|March 29, 2011
VSL#3 for ulcerative colitis: growing evidence?Frank I Scott, Faten Aberra
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2021
Closing the Gap: the Real-World Risk of Serious Infections With Vedolizumab in Comparison With Anti-TNF Therapy in Inflammatory Bowel DiseaseWaseem Ahmed, Frank I Scott
JAMA Pediatrics|December 28, 2016
Antibiotics and Obesity-A Burgeoning or Thinning Argument?Frank I Scott, Ronac Mamtani
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 11, 2019
Bridging Gaps in Evidence-based Clinical Practice in Inflammatory Bowel Diseases: Observational Comparative Effectiveness Research for the WinFrank I Scott, Siddharth Singh
Alimentary Pharmacology & Therapeutics|October 31, 2018
Editorial: which inflammatory bowel disease patients should be screened for Epstein-Barr virus infection?Amneet K Hans, Frank I Scott
Clinics in Colon and Rectal Surgery|January 18, 2014
Medical management of crohn diseaseFrank I Scott, Mark T Osterman
Current Treatment Options in Gastroenterology|January 24, 2014
Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel DiseaseFrank I Scott, Gary R Lichtenstein
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Digestive Diseases and Sciences|April 28, 2020
Infliximab Versus Biosimilars for IBD: Is It Better to Fight Than Switch?Frank I Scott
Crohn'S & Colitis 360|May 5, 2020
Marijuana Use in Inflammatory Bowel Disease: Understanding the Prevalence and the Potential PitfallsFrank I Scott
Current Opinion in Gastroenterology|May 27, 2020
The treatment approach to inflammatory bowel disease in 2020Ashley Vachon, Frank I Scott
Gastroenterology|March 29, 2011
VSL#3 for ulcerative colitis: growing evidence?Frank I Scott, Faten Aberra
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2021
Closing the Gap: the Real-World Risk of Serious Infections With Vedolizumab in Comparison With Anti-TNF Therapy in Inflammatory Bowel DiseaseWaseem Ahmed, Frank I Scott
JAMA Pediatrics|December 28, 2016
Antibiotics and Obesity-A Burgeoning or Thinning Argument?Frank I Scott, Ronac Mamtani
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 11, 2019
Bridging Gaps in Evidence-based Clinical Practice in Inflammatory Bowel Diseases: Observational Comparative Effectiveness Research for the WinFrank I Scott, Siddharth Singh
Alimentary Pharmacology & Therapeutics|October 31, 2018
Editorial: which inflammatory bowel disease patients should be screened for Epstein-Barr virus infection?Amneet K Hans, Frank I Scott
Clinics in Colon and Rectal Surgery|January 18, 2014
Medical management of crohn diseaseFrank I Scott, Mark T Osterman
Current Treatment Options in Gastroenterology|January 24, 2014
Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel DiseaseFrank I Scott, Gary R Lichtenstein
Pageof 10